DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361
DRG International, Inc. began a recall of DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 on . FDA classified it as Class II and gives the reason as "The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High)...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-0921-2025
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- DRG International, Inc.
- Product
- DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361
- Product code
- CFP Radioimmunoassay, Immunoreactive Insulin
- Reason for recall
- The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
- Root cause tag
- manufacturing process
- FDA root cause
- Nonconforming Material/Component
- Action
- DRG International began notifying consignees on 10/07/2024 via letter. Consignees were instructed to check inventory for affected units, cease use of them, and quarantine all product. Arrange return of those units. Consignees were also instructed to notify customers if units were further distributed.
- Quantity in commerce
- 10 units
- Distribution
- Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
- Product codes and lots
- UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0921-2025 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
